Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids

  • Technology appraisal guidance
  • TA832
  • Published: 

Register as a stakeholder

Tools and resources

Tools and resources to help you put the guidance into practice.

Resource impact

Guidance into practice